Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type.
Journal
Leukemia
ISSN: 1476-5551
Titre abrégé: Leukemia
Pays: England
ID NLM: 8704895
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
24
04
2019
accepted:
03
07
2019
revised:
04
06
2019
pubmed:
29
8
2019
medline:
6
2
2020
entrez:
29
8
2019
Statut:
ppublish
Résumé
Chronic myeloid leukemia is driven by a hybrid gene, BCR-ABL1, that codes for a leukemogenic tyrosine kinase (TK) protein of 210 KDa (p210
Identifiants
pubmed: 31455852
doi: 10.1038/s41375-019-0562-1
pii: 10.1038/s41375-019-0562-1
doi:
Substances chimiques
Antineoplastic Agents
0
Protein Kinase Inhibitors
0
Fusion Proteins, bcr-abl
EC 2.7.10.2
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM